Clinical Trial: Locobase® REPAIR Used as an Adjunctive to Standard Therapy in Children With Moderate to Severe Atopic Dermatitis
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Phase IV,Open Label Study of the Treatment of Children With Moderate to Severe Atopic Dermatitis (AD) Using Locobase® REPAIR as an Adjunctive to Standard Treatment
Brief Summary: To assess the efficacy of Locobase REPAIR® when used in children with moderate to severe AD
Detailed Summary:
Sponsor: Astellas Pharma Europe B.V.
Current Primary Outcome: Change in mEASI from baseline to week 3 [ Time Frame: 3 Weeks ]
Original Primary Outcome: Same as current
Current Secondary Outcome: Physicians Global Evaluation of Clinical Response [ Time Frame: 6 Weeks ]
Original Secondary Outcome: Same as current
Information By: Astellas Pharma Inc
Dates:
Date Received: May 6, 2008
Date Started: March 2008
Date Completion:
Last Updated: August 22, 2014
Last Verified: August 2014